Japan Tobacco Inc. has synthesized phospholipase D1 (PLD1) and PLD2 inhibitors reported to be useful for the treatment of cancer and thrombosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results